Literature DB >> 4074618

Evaluation of gastrointestinal motility using the hydrogen breath test.

M Van Wyk, D K Sommers, A G Steyn.   

Abstract

The purpose of the study was to evaluate the validity of a model where intestinal transit is increased and decreased by motility modifying drugs. The measurement of breath hydrogen concentrations after ingestion of lactulose was used to estimate small intestinal transit time. After obtaining base-line values, eight healthy volunteers were pretreated on separate occasions with loperamide, diphenoxylate, metoclopramide and cisapride. Diphenoxylate caused a significant increase in small bowel transit time, whereas both metoclopramide and cisapride significantly shortened it. The H2 breath test therefore seems to accurately reflect the expected transit time. Loperamide did not alter significantly intestinal transit. Possibly this drug counteracts its own delaying influence on small bowel transit by hurrying gastric emptying. Alternatively, not enough time was allowed for it to exert its full effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074618      PMCID: PMC1400726          DOI: 10.1111/j.1365-2125.1985.tb05101.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Production and excretion of hydrogen gas in man.

Authors:  M D Levitt
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

Review 2.  Methods in human alimentary motility.

Authors:  I Trotman; G Misiewicz
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

3.  Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea.

Authors:  N W Read; C A Miles; D Fisher; A M Holgate; N D Kime; M A Mitchell; A M Reeve; T B Roche; M Walker
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

4.  Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

Authors:  J H Bond; M D Levitt; R Prentiss
Journal:  J Lab Clin Med       Date:  1975-04

Review 5.  Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

6.  Prolonged small-intestinal transit time in cystic fibrosis.

Authors:  A Bali; D E Stableforth; P Asquith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

7.  Role of loperamide and placebo in management of irritable bowel syndrome (IBS).

Authors:  P A Cann; N W Read; C D Holdsworth; D Barends
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

8.  Hydrogen (H2) catabolism in the colon of the rat.

Authors:  M D Levitt; T Berggren; J Hastings; J H Bond
Journal:  J Lab Clin Med       Date:  1974-08

9.  Small bowel transit time of food in man: measurement, regulation and possible importance.

Authors:  N W Read
Journal:  Scand J Gastroenterol Suppl       Date:  1984

10.  Use of pulmonary hydrogen (H 2 ) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients.

Authors:  J H Bond; M D Levitt
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

  10 in total
  14 in total

Review 1.  Mechanisms of cisapride affecting gallbladder motility.

Authors:  R von Kiedrowski; S Huijghebaert; R Raedsch
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

2.  Effect of erythromycin on the oro-caecal transit time in man.

Authors:  J Lehtola; P Jauhonen; A Kesäniemi; R Wikberg; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Role of fasting gastrointestinal motility in the variability of gastrointestinal transit time assessed by hydrogen breath test.

Authors:  C Di Lorenzo; C P Dooley; J E Valenzuela
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

4.  Meta-analysis of oro-cecal transit time in fasting subjects.

Authors:  Tohru Kokubo; Shigeyuki Matsui; Makio Ishiguro
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

5.  Loperamide and oro-caecal transit delay.

Authors:  G Basilisco; G Camboni; A Bozzani; P A Bianchi
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

6.  Oral naloxone antagonizes loperamide-induced delay of orocecal transit.

Authors:  G Basilisco; G Camboni; A Bozzani; M Paravicini; P A Bianchi
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

Review 7.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.

Authors:  R W McCallum; C Prakash; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

8.  The effect of short-term dietary fibre administration on oro-caecal transit time in dogs.

Authors:  K Papasouliotis; P Muir; T J Gruffydd-Jones; P J Cripps; A C Blaxter
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

Review 9.  Racecadotril versus loperamide: antidiarrheal research revisited.

Authors:  S Huighebaert; F Awouters; G N J Tytgat
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

10.  Orocaecal transit time in patients with Crohn disease.

Authors:  H Götze; A Ptok
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.